Plain-English translation of NCT06842303 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
Pancreatic cancer is very difficult to treat, and doctors need better ways to know whether treatment is actually working. This study is testing two new types of MRI scanning techniques—advanced diffusion imaging and magnetic resonance elastography—to see if they can more accurately measure how well chemotherapy or surgery is helping. These new scanning methods may help doctors make better decisions about your care.
Pancreatic cancer is one of the hardest cancers to fight, and traditional imaging sometimes cannot clearly show whether a patient is responding to treatment. This new imaging technology could give doctors better, earlier information about whether the treatment approach is working, so they can adjust your care plan if needed.
You likely qualify if…
You likely don't qualify if…
Your role depends on your type of pancreatic cancer. If your cancer can be removed with surgery, you will have surgery. If your cancer is borderline, you may receive chemotherapy first and then possibly surgery. If your cancer is locally advanced, you will receive chemotherapy. Throughout your treatment, you will undergo the new MRI scans at scheduled visits so doctors can track how well the treatment is working using these advanced imaging techniques.
AI-generated summary from trial data · Jul 18, 2026 · Not medical advice
France